These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8955772)

  • 1. Oral pyridoxine in the prevention of oxalate kidney stones.
    Goldenberg RM; Girone JA
    Am J Nephrol; 1996; 16(6):552-3. PubMed ID: 8955772
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones.
    Gershoff SN; Prien EL
    Am J Clin Nutr; 1967 May; 20(5):393-9. PubMed ID: 6023850
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium oxalate renal stones.
    Prien EL
    Annu Rev Med; 1975; 26():173-9. PubMed ID: 1096755
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of oxaluria reduction in pyridoxine prevention of Ca-oxalate nephrolithiasis (author's transl)].
    Revúsová V; Gratzlová J; Zvara V; Krídl J; Suchánek B
    Cas Lek Cesk; 1982 Feb; 121(6):163-6. PubMed ID: 7060073
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effects of anticalculus management in the rat.
    Selikowitz SM; Olsson CA
    Invest Urol; 1976 Sep; 14(2):120-3. PubMed ID: 972003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Minar E
    Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tetracycline on calcium oxalate calculi: in vivo and in vitro studies.
    Selikowitz SM; Olsson CA
    Invest Urol; 1976 Sep; 14(2):124-7. PubMed ID: 972004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Animal-experiment studies on the effect of magnesium and vitamin B 6 on calcium-oxalate nephrolithiasis].
    Schneider HJ; Hesse A; Berg W; Kirsten J; Nickel H
    Z Urol Nephrol; 1977 Jun; 70(6):419-27. PubMed ID: 906678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of long-term pyridoxine administration on serum and urinary values of calculi-forming substances in Ca-oxalate urolithiasis].
    Revúsová V; Gratzlová J; Zvara V; Krídl J; Suchánek B
    Vnitr Lek; 1978 May; 24(5):445-50. PubMed ID: 96593
    [No Abstract]   [Full Text] [Related]  

  • 10. Re.: Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones.
    Assimos D
    J Urol; 2011 May; 185(5):1747. PubMed ID: 22088705
    [No Abstract]   [Full Text] [Related]  

  • 11. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria.
    Yendt ER; Cohanim M
    N Engl J Med; 1985 Apr; 312(15):953-7. PubMed ID: 3974685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No contribution of ascorbic acid to renal calcium oxalate stones.
    Gerster H
    Ann Nutr Metab; 1997; 41(5):269-82. PubMed ID: 9429689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron paramagnetic resonance study of iron oxalate in calcium oxalate renal stones.
    Shields H; Sane D; Resnick MI
    Invest Urol; 1979 May; 16(6):428-31. PubMed ID: 221436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies of Magurlit granulates].
    Frang D; Verebélyi A; Nagy Z
    Acta Chir Acad Sci Hung; 1978; 19(4):363-72. PubMed ID: 757918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of magnesium and pyridoxine on formation of calcium oxalate sones in man.
    Nutr Rev; 1967 Oct; 25(10):304-5. PubMed ID: 4861850
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study on several models of experimental renal calcium oxalate stones formation in rats.
    Liu J; Cao Z; Zhang Z; Zhou S; Ye Z
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):83-7. PubMed ID: 17393118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental oxalic lithiasis: anticrystallizing role of female hormones].
    Tanret P; Thomas J; Thomas E; Balan L
    Rein Foie; 1969-1970; 12():35-54. PubMed ID: 5405909
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.
    Morgan SH; Maher ER; Purkiss P; Watts RW; Curtis JR
    Nephrol Dial Transplant; 1988; 3(1):28-32. PubMed ID: 3132636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of oxalate and phosphate lithiasis by alanine.
    Chow FH; Hamar DW; Udall RH
    Invest Urol; 1974 Jul; 12(1):50-3. PubMed ID: 4835490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.